# PetLife Pharmaceuticals, Inc.

PetLife Pharmaceuticals, Inc. is a company headquartered in Los Angeles,, CA, United States.

## Company overview

- **Legal name:** PetLife Pharmaceuticals, Inc.
- **Former names in filing history:** ECO VENTURES GROUP, INC. (2011-06-02 to 2014-08-05); Modern Renewable Technologies, Inc. (2010-01-14 to 2011-04-14); Vault Technology, Inc. (2008-05-07 to 2009-12-15); GENESIS URANIUM CORP. (2007-11-29 to 2008-04-21); AZTEK VENTURES INC. (2006-04-13 to 2007-10-23)
- **Classification:** Company
- **Industry (SIC):** 2860 — Industrial Organic Chemicals
- **Headquarters:** Los Angeles,, CA, United States
- **Incorporated in:** NV
- **Fiscal year end:** August 31
- **SEC CIK:** 0001354591

## About

PetLife Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001354591, and its reported industry is Industrial Organic Chemicals. In 10-K filed on 2017-12-15, it reported net income of USD -23,256,850; total assets of USD 55,004 for the fiscal period ended 2017-08-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2017 (period ended 2017-08-31)

- **Net income:** -$23.3M (USD -23,256,850)
- **Total assets:** $55,004 (USD 55,004)
- **Cash and equivalents:** $54,254 (USD 54,254)
- **Operating cash flow:** -$318,918 (USD -318,918)

### FY2016 (period ended 2016-08-31)

- **Net income:** -$3.7M (USD -3,687,040)
- **Total assets:** $1,172 (USD 1,172)
- **Cash and equivalents:** $1,172 (USD 1,172)
- **Operating cash flow:** -$151,839 (USD -151,839)

### FY2015 (period ended 2015-08-31)

- **Net income:** -$1.9M (USD -1,935,599)
- **Total assets:** $5,400 (USD 5,400)
- **Operating cash flow:** -$22,034 (USD -22,034)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2014 (period ended 2014-08-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$1.5M (USD -1,512,051)
- **Total assets:** $17,434 (USD 17,434)
- **Cash and equivalents:** $6,852 (USD 6,852)
- **Operating cash flow:** -$267,066 (USD -267,066)

## Recent SEC filings

- Form 8-K — filed 2020-01-30 — period 2020-01-30
- Form 8-K — filed 2020-01-16 — period 2020-01-15
- Form 10-Q — filed 2018-07-17 — period 2018-02-28
- Form 8-K — filed 2018-06-06 — period 2018-05-30
- Form 8-K — filed 2018-03-29 — period 2018-03-25
- Form 8-K — filed 2018-03-28 — period 2018-03-22
- Form 10-Q — filed 2018-01-22 — period 2017-11-30
- Form 8-K — filed 2018-01-18 — period 2018-01-11
- Form 10-K — filed 2017-12-15 — period 2017-08-31
- Form 10-Q — filed 2017-07-18 — period 2017-05-31
- Form 8-K — filed 2017-05-31 — period 2017-05-22
- Form 8-K — filed 2017-05-30 — period 2017-05-30

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/petlife-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology